North America Point-of-Care Molecular Diagnostics Market to Grow at a CAGR of 13.7% to reach US$ 2,110.1 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Point-of-Care Molecular Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Opportunities

5.2.1 Rising R&D and Innovation in Point- of-Care Molecular Diagnostics

5.3 Future Trends

5.3.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits Across Residential Setting

5.4 Impact of Drivers and Restraints

6. North America Point-of-Care Molecular Diagnostics Market Regional Analysis

6.1 North America Point-of-Care Molecular Diagnostics Market Overview

6.2 North America Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 North America Point-of-Care Molecular Diagnostics Market Forecast Analysis

7. North America Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services

7.1 Assays and Kits

7.1.1 Overview
7.1.2 Assays and Kits: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Services and Software

7.3.1 Overview
7.3.2 Services and Software: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Point-of-Care Molecular Diagnostics Market Analysis – by Technology

8.1 PCR

8.1.1 Overview
8.1.2 PCR: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Isothermal Nucleic Acid Amplification Technology

8.2.1 Overview
8.2.2 Isothermal Nucleic Acid Amplification Technology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Other Technologies

8.3.1 Overview
8.3.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Point-of-Care Molecular Diagnostics Market Analysis – by Application

9.1 Infectious Diseases

9.1.1 Overview
9.1.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Oncology

9.2.1 Overview
9.2.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Hematology

9.3.1 Overview
9.3.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Prenatal Testing

9.4.1 Overview
9.4.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Endocrinology

9.5.1 Overview
9.5.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Other Applications

9.6.1 Overview
9.6.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Point-of-Care Molecular Diagnostics Market – North America Analysis

10.1 North America

10.1.1 North America Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
10.1.1.1.2 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
10.1.1.1.3 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application

10.1.1.2 Canada: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
10.1.1.2.2 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
10.1.1.2.3 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application

10.1.1.3 Mexico : North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
10.1.1.3.2 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
10.1.1.3.3 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Point-of-Care Molecular Diagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 bioMérieux SA

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 F. Hoffmann-La Roche Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Danaher Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Enzo Biochem, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 binx health, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Meridian BioScience, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Biocartis

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Quidel Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Bio-Rad Laboratories, Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

bioMérieux SA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Enzo Biochem, Inc.
Abbott
binx health, Inc.
Meridian BioScience, Inc.
Biocartis
Quidel Corporation
Bio-Rad Laboratories, Inc.